TSX News -
VBI Vaccines Announces Phase 3 Clinical Program for Sci-B-Vac(TM) Hepatitis B Vaccine
CAMBRIDGE, MASSACHUSETTS–(Marketwired – July 11, 2017) – VBI Vaccines Inc. (NASDAQ:VBIV)(TSX:VBV) (“VBI”) announced today its plans for a global Phase […]